Exact Mass: 286.059

Exact Mass Matches: 286.059

Found 113 metabolites which its exact mass value is equals to given mass value 286.059, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

oxazepam

oxazepam

C15H11ClN2O2 (286.0509)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent CONFIDENCE standard compound; INTERNAL_ID 799; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8781; ORIGINAL_PRECURSOR_SCAN_NO 8778 CONFIDENCE standard compound; INTERNAL_ID 799; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8746; ORIGINAL_PRECURSOR_SCAN_NO 8744 CONFIDENCE standard compound; INTERNAL_ID 799; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4409; ORIGINAL_PRECURSOR_SCAN_NO 4408 CONFIDENCE standard compound; INTERNAL_ID 799; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8712; ORIGINAL_PRECURSOR_SCAN_NO 8710 CONFIDENCE standard compound; INTERNAL_ID 799; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4423; ORIGINAL_PRECURSOR_SCAN_NO 4421 CONFIDENCE standard compound; INTERNAL_ID 799; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8742; ORIGINAL_PRECURSOR_SCAN_NO 8740 CONFIDENCE standard compound; INTERNAL_ID 799; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8757; ORIGINAL_PRECURSOR_SCAN_NO 8755 CONFIDENCE standard compound; INTERNAL_ID 799; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4422; ORIGINAL_PRECURSOR_SCAN_NO 4421 CONFIDENCE standard compound; INTERNAL_ID 799; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4393; ORIGINAL_PRECURSOR_SCAN_NO 4390 CONFIDENCE standard compound; INTERNAL_ID 799; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8709; ORIGINAL_PRECURSOR_SCAN_NO 8708 CONFIDENCE standard compound; INTERNAL_ID 799; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4374; ORIGINAL_PRECURSOR_SCAN_NO 4372 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1083 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2743 CONFIDENCE standard compound; INTERNAL_ID 8604 CONFIDENCE standard compound; INTERNAL_ID 2680

   

Glycineamideribotide

{[(2R,3S,4R,5R)-5-(2-aminoacetamido)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C7H15N2O8P (286.0566)


Glycinamidoribotide conversion to N-formylglycinamide ribonucleotide is the third reaction of the de novo purine biosynthesis, a reaction catalyzed by the enzyme Glycinamide ribonucleotide transformylase (EC 2.1.2.2), with concomitant conversion of 10-formyltetrahydrofolate to tetrahydrofolate. (PMID: 9143358). Glycineamideribotide formation is stimulated by Luteinizing hormone (LH) and Chorionic gonadotropin (HCG) via activation of Glc-6-P-dehydrogenase (EC 1.1.1.49). (PMID: 4366083) [HMDB] Glycinamidoribotide conversion to N-formylglycinamide ribonucleotide is the third reaction of the de novo purine biosynthesis, a reaction catalyzed by the enzyme Glycinamide ribonucleotide transformylase (EC 2.1.2.2), with concomitant conversion of 10-formyltetrahydrofolate to tetrahydrofolate. (PMID: 9143358). Glycineamideribotide formation is stimulated by Luteinizing hormone (LH) and Chorionic gonadotropin (HCG) via activation of Glc-6-P-dehydrogenase (EC 1.1.1.49). (PMID: 4366083).

   

Phenyl-P

2-Methacryloyloxyethyl phenyl phosphate

C12H15O6P (286.0606)


   

Oxazepam

7-chloro-3-hydroxy-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one

C15H11ClN2O2 (286.0509)


Oxazepam is only found in individuals that have used or taken this drug. It is an intermediate-acting benzodiazepine used to treat alcohol withdrawal and anxiety disorders. It is a metabolite of diazepam, prazepam, temazepam, and clorazepate, and has moderate amnesic, anxiolytic, anticonvulsant, hypnotic, sedative, and skeletal muscle relaxant properties compared to other benzodiazepines (Wikipedia). Like other benzodiazepines, oxazepam exerts its anxiolytic effects by potentiating the effect of gamma-aminobutyric acid (GABA) on GABA-A receptors through a cooperative mechanism of action. GABA receptors are ionotropic chloride-linked channel receptors that produce inhibitory postsynaptic potentials. When activated by GABA, the GABA receptor/chloride ionophore complex undergoes a conformational change that allows the passage of chloride ions through the channel. Benzodiazepines are believed to exert their effect by increasing the effect of GABA at its receptor. Benzodiazepine binding increases chloride conductance in the presence of GABA by increasing the frequency at which the channel opens. In contrast, barbiturates increase chloride conductance in the presence of GABA by prolonging the time in which the channel remains open. There are 18 subtypes of the GABA receptor subunits. The α2 subunit of the α2β3γ2 receptor complex is thought to mediate anxiolytic effects while the α1 subunit of the α1β2γ2 receptor complex is thought to mediate sedative, anticonvulsant, and anterograde amnesia effects. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

norclobazam

8-chloro-4-hydroxy-1-phenyl-2,3-dihydro-1H-1,5-benzodiazepin-2-one

C15H11ClN2O2 (286.0509)


norclobazam is a metabolite of clobazam. Clobazam (marketed under the brand names Frisium, Urbanol and Onfi), is a drug which is a benzodiazepine derivative. It has been marketed as an anxiolytic since 1975 and an anticonvulsant since 1984. (Wikipedia) D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

p-Hydroxynordiazepam

7-chloro-5-(4-hydroxyphenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one

C15H11ClN2O2 (286.0509)


p-Hydroxynordiazepam is a metabolite of clorazepate. Clorazepate (marketed under the brand names Tranxene and Novo-Clopate), also known as clorazepate dipotassium, is a drug that is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, hypnotic and skeletal muscle relaxant properties. Clorazepate is a prodrug for desmethyldiazepam, which is rapidly produced as an active metabolite. Desmethyldiazepam is responsible for most of the therapeutic effects of clorazepate. (Wikipedia)

   

Uralenneoside

3,4,5-Trihydroxyoxan-2-yl 3,4-dihydroxybenzoic acid

C12H14O8 (286.0689)


Uralenneoside is found in herbs and spices. Uralenneoside is a constituent of the leaves of Glycyrrhiza uralensis (Chinese licorice). Constituent of the leaves of Glycyrrhiza uralensis (Chinese licorice). Uralenneoside is found in herbs and spices.

   

3'-Methoxyfukiic acid

2,3-dihydroxy-2-[(4-hydroxy-3-methoxyphenyl)methyl]butanedioic acid

C12H14O8 (286.0689)


3-Methoxyfukiic acid is found in green vegetables. 3-Methoxyfukiic acid is isolated from Petasites japonicus (sweet coltsfoot

   

Demoxepam

7-chloro-2-hydroxy-5-phenyl-3H-1,4λ⁵-benzodiazepin-4-one

C15H11ClN2O2 (286.0509)


Demoxepam belongs to the family of Benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms).

   

Diphenol glucuronide

(2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(2-hydroxyphenoxy)oxane-2-carboxylic acid

C12H14O8 (286.0689)


Diphenol glucuronide belongs to the family of Glucuronides. These are compounds comprising the glucuronic acid linked to another substance via a glycosidic bond.

   

Catechol glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-hydroxyphenoxy)oxane-2-carboxylic acid

C12H14O8 (286.0689)


   

Fenclorac

alpha-m-Dichloro-p-cyclohexylphenylacetic acid diethylammonium salt

C14H16Cl2O2 (286.0527)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

   

Imirestat

Spiro(2,7-difluoro-9H-fluoren-9,4-imidazolidine)-2,5-dione

C15H8F2N2O2 (286.0554)


C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor

   

9-(6-Oxo-1H-purin-9-yl)-3H-purine-2,6-dione

3,6-dihydro-1H,1H,2H,6H-[9,9-bipurine]-2,6,6-trione

C10H6N8O3 (286.0563)


   

Tauromustine

N-(2-Chloroethyl)-2-(dimethylsulphamoyl)-N-nitrosoethane-1-carbamimidic acid

C7H15ClN4O4S (286.0502)


   

Quinol glucuronide

3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxane-2-carboxylic acid

C12H14O8 (286.0689)


   
   

2-hydroxy-1H-naphtho[2,1,8-mna]xanthen-1-one

2-hydroxy-1H-naphtho[2,1,8-mna]xanthen-1-one

C19H10O3 (286.063)


   

5-Hydroxy-1H-naphtho[2,1,8-mna]xanthen-1-one

5-Hydroxy-1H-naphtho[2,1,8-mna]xanthen-1-one

C19H10O3 (286.063)


   

Demoxepam

Demoxepam

C15H11ClN2O2 (286.0509)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent

   

Maybridge1_006093

Maybridge1_006093

C14H11FN4S (286.0688)


   
   

5-O-beta-xylopyranosyl gentisic acid

5-O-beta-xylopyranosyl gentisic acid

C12H14O8 (286.0689)


   

2-methoxy-6-[5-(prop-1-yn-1-yl)-2-thienyl]-hexa-3,5-diyn-1-yl acetate

2-methoxy-6-[5-(prop-1-yn-1-yl)-2-thienyl]-hexa-3,5-diyn-1-yl acetate

C16H14O3S (286.0664)


   

3-alpha-L-arabinopyranosyloxy-4-hydroxybenzoic acid

3-alpha-L-arabinopyranosyloxy-4-hydroxybenzoic acid

C12H14O8 (286.0689)


   
   

gentisate 5-O-beta-D-xylopyranoside

gentisate 5-O-beta-D-xylopyranoside

C12H14O8 (286.0689)


   

Norclobazam

N-Desmethyl Clobazam

C15H11ClN2O2 (286.0509)


D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Dihydrobenzoic acid pentose

Dihydrobenzoic acid pentose

C12H14O8 (286.0689)


Annotation level-3

   

Benzoic acid + 2O, O-Pen

Benzoic acid + 2O, O-Pen

C12H14O8 (286.0689)


Annotation level-3

   

2,2-dimethyl-8-(phenylthio)-4H-benzo[d][1,3]dioxin-4-one

2,2-dimethyl-8-(phenylthio)-4H-benzo[d][1,3]dioxin-4-one

C16H14O3S (286.0664)


   

Pyrocatechol glucuronide

Pyrocatechol glucuronide

C12H14O8 (286.0689)


   

Quinol glucuronide

Quinol glucuronide

C12H14O8 (286.0689)


   

N-Desmethylclobazam

N-Desmethyl Clobazam

C15H11ClN2O2 (286.0509)


   

Phosphoribosylglycinamide

Phosphoribosylglycinamide

C7H15N2O8P (286.0566)


   

3'-Methoxyfukiic acid

2,3-dihydroxy-2-[(4-hydroxy-3-methoxyphenyl)methyl]butanedioic acid

C12H14O8 (286.0689)


   

Uralenneoside

3,4,5-trihydroxyoxan-2-yl 3,4-dihydroxybenzoate

C12H14O8 (286.0689)


   

3,4-diphenylthiophene-2,5-dicarbonitrile

3,4-diphenylthiophene-2,5-dicarbonitrile

C18H10N2S (286.0565)


   

N-(4-AMINO-2-METHYLPHENYL)-4-CHLOROPHTHALIMIDE

N-(4-AMINO-2-METHYLPHENYL)-4-CHLOROPHTHALIMIDE

C15H11ClN2O2 (286.0509)


   

6-chloro-4-phenyl-1,4-dihydroquinazoline-2-carboxylic acid

6-chloro-4-phenyl-1,4-dihydroquinazoline-2-carboxylic acid

C15H11ClN2O2 (286.0509)


   

Tauromustine

Tauromustine

C7H15ClN4O4S (286.0502)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents

   

Olprinone hydrochloride

Olprinone (Hydrochloride)

C14H11ClN4O (286.0621)


D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058987 - Phosphodiesterase 3 Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

2-FLUORO-2-METHANESULFONYLOXYMETHYL-MALONIC ACID DIETHYL ESTER

2-FLUORO-2-METHANESULFONYLOXYMETHYL-MALONIC ACID DIETHYL ESTER

C9H15FO7S (286.0522)


   

1-methyl-5-phenoxy-3-(trifluoromethyl)pyrazole-4-carboxylic acid

1-methyl-5-phenoxy-3-(trifluoromethyl)pyrazole-4-carboxylic acid

C12H9F3N2O3 (286.0565)


   

2-(4-amino-3-nitrobenzoyl)benzoic acid

2-(4-amino-3-nitrobenzoyl)benzoic acid

C14H10N2O5 (286.059)


   

(4-METHOXY-BENZYL)-PYRIDIN-3-YL-AMINE DIHYDROCHLORIDE

(4-METHOXY-BENZYL)-PYRIDIN-3-YL-AMINE DIHYDROCHLORIDE

C13H16Cl2N2O (286.064)


   

5-METHYL-2-(4-TRIFLUOROMETHOXYPHENYL)-3H-IMIDAZOLE-4-CARBOXYLIC ACID

5-METHYL-2-(4-TRIFLUOROMETHOXYPHENYL)-3H-IMIDAZOLE-4-CARBOXYLIC ACID

C12H9F3N2O3 (286.0565)


   

2-[[2-(benzylsulfonylamino)acetyl]amino]acetate

2-[[2-(benzylsulfonylamino)acetyl]amino]acetate

C11H14N2O5S (286.0623)


   

3-[(4-acetamidophenyl)sulfonylamino]propanoic acid

3-[(4-acetamidophenyl)sulfonylamino]propanoic acid

C11H14N2O5S (286.0623)


   

4-[(1-phenyl-1H-tetrazol-5-yl)thio]pyrocatechol

4-[(1-phenyl-1H-tetrazol-5-yl)thio]pyrocatechol

C13H10N4O2S (286.0524)


   

4-(BENZYLOXY)BENZENE-1,2-DIAMINE DIHYDROCHLORIDE

4-(BENZYLOXY)BENZENE-1,2-DIAMINE DIHYDROCHLORIDE

C13H16Cl2N2O (286.064)


   

Thieno[3,4-b]-1,4-dioxin-5,7-dicarboxylic acid, 2,3-dihydro-, diethyl ester

Thieno[3,4-b]-1,4-dioxin-5,7-dicarboxylic acid, 2,3-dihydro-, diethyl ester

C12H14O6S (286.0511)


   

4-methoxy-6-methyl-5-nitro-2-(trifluoromethyl)quinoline

4-methoxy-6-methyl-5-nitro-2-(trifluoromethyl)quinoline

C12H9F3N2O3 (286.0565)


   

6-chloro-4-phenyl-1,2-dihydroquinazoline-2-carboxylic acid

6-chloro-4-phenyl-1,2-dihydroquinazoline-2-carboxylic acid

C15H11ClN2O2 (286.0509)


   

(4,6-DIMETHYL-PYRIMIDIN-2-YLSULFANYL)-PHENYL-ACETICACID

(4,6-DIMETHYL-PYRIMIDIN-2-YLSULFANYL)-PHENYL-ACETICACID

C11H14N2O5S (286.0623)


   

3-(BENZO[D]THIAZOL-2-YL)-4,5,6,7-TETRAHYDROBENZO[B]THIOPHEN-2-AMINE

3-(BENZO[D]THIAZOL-2-YL)-4,5,6,7-TETRAHYDROBENZO[B]THIOPHEN-2-AMINE

C15H14N2S2 (286.0598)


   

2-(5-chloro-2-methoxyphenyl)-4-pyridin-2-yl-1,3-oxazole

2-(5-chloro-2-methoxyphenyl)-4-pyridin-2-yl-1,3-oxazole

C15H11ClN2O2 (286.0509)


   

Tosyl-L-asparagine

Tosyl-L-asparagine

C11H14N2O5S (286.0623)


   

1-(4-methoxyphenyl)-5-(trifluoromethyl)pyrazole-4-carboxylic acid

1-(4-methoxyphenyl)-5-(trifluoromethyl)pyrazole-4-carboxylic acid

C12H9F3N2O3 (286.0565)


   

1-(4-Chloro-1H-pyrrolo[2,3-b]pyridin-5-yl)-2-phenoxyethanone

1-(4-Chloro-1H-pyrrolo[2,3-b]pyridin-5-yl)-2-phenoxyethanone

C15H11ClN2O2 (286.0509)


   

5-(AMINOSULFONYL)-2-MORPHOLIN-4-YLBENZOIC ACID

5-(AMINOSULFONYL)-2-MORPHOLIN-4-YLBENZOIC ACID

C11H14N2O5S (286.0623)


   

4-(furan-2-ylmethyl)-2,3-dihydro-1H-quinoxaline

4-(furan-2-ylmethyl)-2,3-dihydro-1H-quinoxaline

C13H16Cl2N2O (286.064)


   

Benzyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate

Benzyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate

C15H11ClN2O2 (286.0509)


   

3-Cyclopentyl-2-(3,4-dichlorophenyl)propanoic acid

3-Cyclopentyl-2-(3,4-dichlorophenyl)propanoic acid

C14H16Cl2O2 (286.0527)


   

2-[3,5-bis(trifluoromethyl)phenyl]-N-hydroxyethanimidamide

2-[3,5-bis(trifluoromethyl)phenyl]-N-hydroxyethanimidamide

C10H8F6N2O (286.0541)


   

4-N,N-Dimethylamino-2-(trimethylstannyl)-pyridine

4-N,N-Dimethylamino-2-(trimethylstannyl)-pyridine

C10H18N2Sn (286.0492)


   

Benzoic acid,2-[[(4-nitrophenyl)amino]carbonyl]-

Benzoic acid,2-[[(4-nitrophenyl)amino]carbonyl]-

C14H10N2O5 (286.059)


   

6-(4-fluorophenyl)-4-methylsulfanylpyrido[3,2-d]pyrimidin-2-amine

6-(4-fluorophenyl)-4-methylsulfanylpyrido[3,2-d]pyrimidin-2-amine

C14H11FN4S (286.0688)


   

Benzoic acid,4,4-(1-oxido-1,2-diazenediyl)bis-

Benzoic acid,4,4-(1-oxido-1,2-diazenediyl)bis-

C14H10N2O5 (286.059)


   

sulfamerazine sodium

sulfamerazine sodium

C11H11N4NaO2S (286.05)


   

Glycine,N-[(4-methylphenyl)sulfonyl]glycyl-

Glycine,N-[(4-methylphenyl)sulfonyl]glycyl-

C11H14N2O5S (286.0623)


   

4(1H)-Quinazolinone,3-(3-fluoro-4-methylphenyl)-2,3-dihydro-2-thioxo-

4(1H)-Quinazolinone,3-(3-fluoro-4-methylphenyl)-2,3-dihydro-2-thioxo-

C15H11FN2OS (286.0576)


   

4-(3-((3-CHLOROPROPANOYL)OXY)PROPOXY)BENZOIC ACID

4-(3-((3-CHLOROPROPANOYL)OXY)PROPOXY)BENZOIC ACID

C13H15ClO5 (286.0608)


   

2-[2-fluoro-4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]sulfanylacetic acid

2-[2-fluoro-4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]sulfanylacetic acid

C13H15FO4S (286.0675)


   

2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-(4-hydroxyphenyl)-

2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-(4-hydroxyphenyl)-

C15H11ClN2O2 (286.0509)


   

1-p-Chlorobenzyl-1H-indazole-3-carboxylic acid

1-p-Chlorobenzyl-1H-indazole-3-carboxylic acid

C15H11ClN2O2 (286.0509)


   

2-(Benzoylamino)-4-nitrobenzoic acid

2-(Benzoylamino)-4-nitrobenzoic acid

C14H10N2O5 (286.059)


   

N-(3-nitrophenyl)-1,3-benzodioxole-5-carboxamide

N-(3-nitrophenyl)-1,3-benzodioxole-5-carboxamide

C14H10N2O5 (286.059)


   

3-[(3-Fluorophenyl)methylthio]-6-(2-furanyl)pyridazine

3-[(3-Fluorophenyl)methylthio]-6-(2-furanyl)pyridazine

C15H11FN2OS (286.0576)


   
   

N(1)-(5-phospho-D-Ribosyl)glycinamide

N(1)-(5-phospho-D-Ribosyl)glycinamide

C7H15N2O8P (286.0566)


   

Fenclorac

Fenclorac

C14H16Cl2O2 (286.0527)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

   

cytosyl-beta-D-glucuronate

cytosyl-beta-D-glucuronate

C10H12N3O7- (286.0675)


   

N-Succinyl-L-2-amino-6-oxoheptanedioate

N-Succinyl-L-2-amino-6-oxoheptanedioate

C11H12NO8-3 (286.0563)


   

2-hydroxy-5-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxybenzoic acid

2-hydroxy-5-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxybenzoic acid

C12H14O8 (286.0689)


   

(2-Methylbenzimidazol-1-yl)-[(5-nitro-2-thienyl)methylene]amine

(2-Methylbenzimidazol-1-yl)-[(5-nitro-2-thienyl)methylene]amine

C13H10N4O2S (286.0524)


   

4-Methoxy-1,3-dimethyl-6-thiophen-2-yl-8-cyclohepta[c]furanone

4-Methoxy-1,3-dimethyl-6-thiophen-2-yl-8-cyclohepta[c]furanone

C16H14O3S (286.0664)


   

2-cyano-3-oxo-N-[4-(trifluoromethoxy)phenyl]butanamide

2-cyano-3-oxo-N-[4-(trifluoromethoxy)phenyl]butanamide

C12H9F3N2O3 (286.0565)


   

2-Hydroxy-3-(beta-D-xylopyranosyloxy)benzoic acid

2-Hydroxy-3-(beta-D-xylopyranosyloxy)benzoic acid

C12H14O8 (286.0689)


   

3-(4-Chlorophenyl)-3-oxo-2-(2-phenylhydrazono)propanal

3-(4-Chlorophenyl)-3-oxo-2-(2-phenylhydrazono)propanal

C15H11ClN2O2 (286.0509)


   

4-oxo-2-(trifluoromethyl)-1H-quinazoline-6-carboxylic acid ethyl ester

4-oxo-2-(trifluoromethyl)-1H-quinazoline-6-carboxylic acid ethyl ester

C12H9F3N2O3 (286.0565)


   

3,4,5-Trihydroxy-6-(2-hydroxyphenoxy)oxane-2-carboxylic acid

3,4,5-Trihydroxy-6-(2-hydroxyphenoxy)oxane-2-carboxylic acid

C12H14O8 (286.0689)


   

[(E)-5-(4-methoxyphenyl)-3-oxopent-4-enyl] hydrogen sulate

[(E)-5-(4-methoxyphenyl)-3-oxopent-4-enyl] hydrogen sulate

C12H14O6S (286.0511)


   

4-Acetoxymethyl-6-chloromethyl-2,5-dimethoxy-2,4,6-cycloheptatrien-1-one

4-Acetoxymethyl-6-chloromethyl-2,5-dimethoxy-2,4,6-cycloheptatrien-1-one

C13H15ClO5 (286.0608)


   

cytosylglucuronate

cytosylglucuronate

C10H12N3O7 (286.0675)


A carbohydrate acid derivative anion that is the conjugate base of cytosylglucuronic acid, obtained by deprotonation of the carboxy group.

   

2-Hydroxyphenyl-beta-D-glucopyranosiduronic acid

2-Hydroxyphenyl-beta-D-glucopyranosiduronic acid

C12H14O8 (286.0689)


   

Diphenol glucuronide

Diphenol glucuronide

C12H14O8 (286.0689)


   

3-Methoxyfukiic acid

3-Methoxyfukiic acid

C12H14O8 (286.0689)


   

2,3-dihydroxybenzoic acid 3-O-beta-D-xyloside

2,3-dihydroxybenzoic acid 3-O-beta-D-xyloside

C12H14O8 (286.0689)


A monohydroxybenzoic acid that is 2-hydroxybenzoic acid in which the hydrogen at position 3 is replaced by a beta-D-xylosyloxy group.

   

catechol beta-D-glucuronide

catechol beta-D-glucuronide

C12H14O8 (286.0689)


A glucosiduronic acid that is beta-D-glucuronic acid in which the anomeric hydroxyl hydrogen has been replaced by a 2-hydroxyphenyl group.

   

methyl 2-[4,5-dimethoxy-2-(methylsulfanyl)-3,6-dioxocyclohexa-1,4-dien-1-yl]acetate

methyl 2-[4,5-dimethoxy-2-(methylsulfanyl)-3,6-dioxocyclohexa-1,4-dien-1-yl]acetate

C12H14O6S (286.0511)


   

4-hydroxy-3-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}benzoic acid

4-hydroxy-3-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}benzoic acid

C12H14O8 (286.0689)


   

2-amino-n-[(3r,4s,5r)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]ethanimidic acid

2-amino-n-[(3r,4s,5r)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]ethanimidic acid

C7H15N2O8P (286.0566)


   

2-hydroxy-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}benzoic acid

2-hydroxy-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}benzoic acid

C12H14O8 (286.0689)


   

4-hydroxy-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]benzoic acid

4-hydroxy-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]benzoic acid

C12H14O8 (286.0689)


   

(2r,3s)-2,3-dihydroxy-2-[(4-hydroxy-3-methoxyphenyl)methyl]butanedioic acid

(2r,3s)-2,3-dihydroxy-2-[(4-hydroxy-3-methoxyphenyl)methyl]butanedioic acid

C12H14O8 (286.0689)


   

(2s)-2-methoxy-6-[5-(prop-1-yn-1-yl)thiophen-2-yl]hexa-3,5-diyn-1-yl acetate

(2s)-2-methoxy-6-[5-(prop-1-yn-1-yl)thiophen-2-yl]hexa-3,5-diyn-1-yl acetate

C16H14O3S (286.0664)


   

3,4,5-trihydroxyoxan-2-yl 2,5-dihydroxybenzoate

3,4,5-trihydroxyoxan-2-yl 2,5-dihydroxybenzoate

C12H14O8 (286.0689)


   

(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl 2,5-dihydroxybenzoate

(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl 2,5-dihydroxybenzoate

C12H14O8 (286.0689)


   

2-hydroxy-5-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}benzoic acid

2-hydroxy-5-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}benzoic acid

C12H14O8 (286.0689)


   

2-methoxy-6-[5-(prop-1-yn-1-yl)thiophen-2-yl]hexa-3,5-diyn-1-yl acetate

2-methoxy-6-[5-(prop-1-yn-1-yl)thiophen-2-yl]hexa-3,5-diyn-1-yl acetate

C16H14O3S (286.0664)